📋 Table of Contents
- Florida Oncology Market: Why RCM Is So Complex
- Oncology CPT & HCPCS Billing Codes 2026
- Chemotherapy Billing: Drug Administration & J-Codes
- Radiation Oncology Billing in Florida
- Medicare Part B Oncology Billing in Florida
- Florida Medicaid & MMA Plans for Oncology
- Prior Authorization & Denial Management
- AI-Powered Oncology RCM: The 2026 Advantage
- MDeRCM Oncology RCM Services in Florida
- FAQ: Oncology Billing Florida 2026
1. Florida Oncology Market: Why RCM Is So Complex
Florida is home to over 850 oncology practices, 60+ NCI-designated cancer centers, and thousands of independent hematology-oncology physicians — making it one of the most competitive and complex oncology billing landscapes in the United States. With the state's large Medicare-age population (Florida ranks #1 nationally for Medicare beneficiaries), oncology revenue cycle management requires deep expertise in Medicare Part B drug reimbursement, incident-to billing, and value-based oncology payment models.
Florida cancer centers face a unique convergence of challenges: high patient volumes, extremely high-cost drug therapies (some exceeding $50,000 per infusion cycle), complex prior authorization requirements from Florida Medicaid Managed Care Organizations (MCOs), and frequent payer policy changes. Without a specialized oncology billing service in Florida, practices routinely leave hundreds of thousands of dollars on the table every year.
- Average oncology claim denial rate in Florida: 28–34%
- Top denial reason: Prior authorization not obtained (41% of denials)
- Average revenue lost per oncology practice annually: $280K–$650K
- Medicare Part B drug reimbursement errors account for 23% of underpayments
- HCPCS J-code billing errors are the #1 chemotherapy coding mistake in Florida
Jacksonville, Orlando, Tampa, Miami, Fort Lauderdale, Naples, Sarasota — each with distinct payer mix dominated by Medicare Advantage and Florida Medicaid MCOs.
Florida has 4.8M+ Medicare beneficiaries (2026). For oncology practices, 60–75% of revenue typically flows through Medicare — making Part B billing accuracy absolutely mission-critical.
Targeted therapies, immunotherapies (pembrolizumab, nivolumab), and CAR-T cell therapies require precise HCPCS J-code assignment, ASP-based reimbursement calculations, and real-time drug pricing updates.
Florida AHCA oversight, Florida Comprehensive Cancer Control Program requirements, and CMS Oncology Care Model (OCM) successor programs add layers of compliance complexity unique to Florida.
2. Oncology CPT & HCPCS Billing Codes 2026
Accurate CPT and HCPCS coding is the foundation of oncology revenue cycle management. In 2026, CMS updated multiple oncology-related codes, and Florida-specific payer policies added additional complexity. Below are the critical code sets every Florida oncology billing team must master.
📋 Core Oncology Evaluation & Management (E/M) Codes
| CPT Code | Description | 2026 Medicare Rate (FL) | Common Error |
|---|---|---|---|
| 99213 | Office visit – established patient, moderate complexity | $96.40 | Upcoding without proper MDM documentation |
| 99214 | Office visit – established patient, high complexity | $136.26 | Missing time-based documentation for complex oncology visits |
| 99215 | Office visit – established patient, highest complexity | $180.11 | Not used when patient complexity warrants it — leads to revenue loss |
| 99242 | Outpatient consultation (non-Medicare) | $124.50 | Billing consult codes to Medicare (not allowed since 2010) |
| 99354 | Prolonged service – first hour | $143.20 | Inadequate documentation of total time spent |
| G0463 | Hospital outpatient clinic visit (HOPD) | $112.00 | Incorrect place of service for hospital-based oncology clinics |
💉 Chemotherapy Administration CPT Codes 2026
| CPT Code | Service | 2026 Rate (FL) | Notes |
|---|---|---|---|
| 96401 | Chemo administration – subcutaneous/IM injection | $28.14 | Initial substance only; do not bill for each additional drug |
| 96409 | Chemo – IV push, single/initial substance | $59.23 | Requires direct physician/nurse supervision documentation |
| 96413 | Chemo – infusion, initial up to 1 hour | $176.47 | Most frequently billed oncology administration code in Florida |
| 96415 | Chemo – infusion, each additional hour | $64.18 | Bill per additional hour beyond the first; requires distinct drug documentation |
| 96416 | Chemo – initiation of prolonged (>8 hrs) infusion | $287.30 | Rare — requires pump and clinical justification notes |
| 96423 | Chemo – IV push, each additional substance | $48.90 | Must document each additional drug separately in notes |
| 96542 | Chemo injection, subarachnoid/intraventricular | $195.60 | Requires specialized facility and physician credential documentation |
🧬 Injection & Infusion (Non-Chemo) Codes Commonly Used in Oncology
| CPT Code | Service | Typical Use in Oncology |
|---|---|---|
| 96360 | IV infusion, hydration – initial, 31 min to 1 hr | Pre/post chemo hydration (billed separately with -59 modifier) |
| 96365 | IV infusion, therapeutic – initial, up to 1 hr | Supportive drugs: antiemetics, steroids, bisphosphonates |
| 96372 | Therapeutic, prophylactic, or diagnostic injection – IM or SQ | Pegfilgrastim (Neulasta), growth factors after chemo |
| 96374 | Therapeutic/prophylactic injection – IV push | Antiemetics, Decadron, diphenhydramine pre-treatment |
| 96379 | Unlisted injection/infusion service | Requires letter of medical necessity; frequently audited |
3. Chemotherapy Billing: Drug Administration & J-Codes
HCPCS J-codes are the backbone of chemotherapy drug reimbursement in Florida. Each oncology drug has a specific J-code tied to its National Drug Code (NDC), unit size, and Average Sales Price (ASP). Errors in J-code assignment or units billed are the #1 cause of chemotherapy billing denials from Medicare and Florida Medicaid MCOs.
- Wrong unit billing: J-codes are priced per specific units (e.g., per mg, per 10 mg, per 100 mg). Billing the wrong unit count = immediate denial or clawback
- Missing NDC on claim: Medicare and most Florida MCOs require NDC on all drug claims — claims without NDC auto-deny
- Using generic NDC instead of brand: Reimbursement rates vary significantly; wrong NDC = underpayment
- Not updating ASP quarterly: CMS updates ASP (Average Sales Price) every quarter — using outdated pricing leads to underpayment
- Billing drug wastage incorrectly: Medicare allows billing for single-dose vial wastage with modifier JW; multi-dose vial wastage is NOT billable
💊 High-Value J-Codes for Florida Oncology Practices (2026)
| J-Code | Drug Name | Common Oncology Use | 2026 ASP+6% Rate (Per Unit) |
|---|---|---|---|
| J9271 | Pembrolizumab (Keytruda) | Lung, melanoma, bladder, head & neck cancers | $4,720/100mg |
| J9299 | Nivolumab (Opdivo) | Lung, RCC, melanoma, GI cancers | $3,810/100mg |
| J9035 | Bevacizumab (Avastin) | Colorectal, lung, glioblastoma | $618/100mg |
| J9190 | Fluorouracil | Colorectal, breast, GI cancers | $4.12/500mg |
| J9355 | Trastuzumab (Herceptin) | HER2+ breast cancer | $1,240/10mg |
| J9217 | Leuprolide acetate (Lupron) | Prostate cancer hormone therapy | $386/1mg |
| J2505 | Pegfilgrastim (Neulasta) | G-CSF support post-chemo | $5,290/6mg |
| J9043 | Cabozantinib (Cabometyx) | RCC, hepatocellular carcinoma | $8,340/60mg |
| J9263 | Oxaliplatin | Colorectal cancer (FOLFOX regimen) | $56/0.5mg |
| J9310 | Rituximab (Rituxan) | B-cell lymphoma, CLL | $1,560/100mg |
* Rates approximate 2026 ASP+6% Medicare reimbursement. Medicaid MCO rates vary by plan. Always verify current quarter ASP from CMS.
🔑 Critical Modifiers for Oncology Drug Billing
Drug amount discarded — single-use vial wastage. Required by Medicare and many FL MCOs. Missing JW = compliance risk and unrecovered revenue.
No discarded drug from single-use vial. Required starting 2023 when no wastage occurs. Pairs with JW to complete documentation.
Distinct procedural service. Used when billing infusion and injection on same day — required to prevent bundling denials.
Significant, separately identifiable E/M on same day as procedure. Critical for oncology office visits paired with drug administration.
Reduced services. Used when full infusion time was not completed (e.g., adverse reaction required early termination).
Assistant at surgery — PA/NP/CNS assisting. Relevant for oncology surgical procedures; affects reimbursement rate.
4. Radiation Oncology Billing in Florida 2026
Radiation oncology has one of the most complex billing structures in all of medicine. Florida's 200+ radiation oncology centers must navigate technical vs. professional component billing, global versus split billing, and frequent payer-specific rules that differ between Medicare, Florida Medicaid, and commercial insurers. A single miscoded treatment planning session can result in thousands of dollars in denied claims.
| CPT Code | Service | Component | 2026 FL Medicare Rate |
|---|---|---|---|
| 77263 | Radiation treatment planning – complex | Professional | $288.50 |
| 77301 | IMRT planning | Technical + Professional | $2,144.00 |
| 77385 | IMRT delivery – simple | Technical | $478.20 |
| 77386 | IMRT delivery – complex | Technical | $1,086.40 |
| 77412 | Radiation treatment delivery – complex | Technical | $348.90 |
| 77427 | Radiation treatment management (5 fractions) | Professional | $278.00 |
| 77435 | Stereotactic body radiation (SBRT) management | Professional | $1,044.00 |
| 77522 | Proton beam therapy – simple without compensation | Technical | $1,324.00 |
| 77523 | Proton beam therapy – intermediate | Technical | $1,860.00 |
| 77300 | Basic radiation dosimetry | Technical | $82.40 |
⚠️ Top Radiation Oncology Billing Errors in Florida
Hospital-based radiation oncology centers often bill both components incorrectly. The technical component belongs to the facility; the professional component belongs to the physician. Billing both under one provider = immediate denial.
Simple vs. intermediate vs. complex planning (77261/77262/77263) requires thorough documentation of simulation techniques, number of beams, and tumor complexity. Miscoding down means significant revenue loss.
IMRT planning codes have a global period — rebilling for follow-up treatment management visits within the global period triggers denials. Florida Medicare Administrative Contractor (First Coast Service Options) aggressively audits this.
For IMRT and SBRT, physics simulation and dosimetry notes must be in the chart and separately signed. Missing signatures = denied claims under Florida Medicaid MCO audits.
5. Medicare Part B Oncology Billing in Florida
Medicare Part B is the dominant payer for oncology services in Florida, covering physician services, outpatient chemotherapy, radiation therapy, and diagnostic tests. Florida's Medicare Administrative Contractor is First Coast Service Options (FCSO) — and understanding FCSO's specific Local Coverage Determinations (LCDs) is essential for Florida oncology billing compliance.
📋 FCSO Key LCDs Affecting Florida Oncology Billing (2026)
- L33550 – Chemotherapy agents: Coverage criteria for specific ICD-10 diagnosis-drug combinations
- L33819 – IMRT: Documentation requirements for treatment planning and delivery
- L34559 – Proton beam therapy: Clinical indications and coverage restrictions
- L34636 – PET scans for oncology: Diagnosis-specific coverage for staging and restaging
- L35062 – Tumor markers: When CA-125, CEA, PSA, AFP are covered
- L33393 – Molecular pathology: Coverage for genetic tumor testing (BRCA, KRAS, EGFR)
💡 Medicare Advantage (Part C) Oncology Billing in Florida — 2026
In Florida, over 55% of Medicare beneficiaries are enrolled in Medicare Advantage plans (as of January 2026), meaning the majority of your Medicare oncology patients are NOT billed under traditional Medicare. Major Florida Medicare Advantage plans for oncology include:
| Medicare Advantage Plan | Florida Enrollment | Oncology PA Requirement | Timely Filing Limit |
|---|---|---|---|
| UnitedHealthcare MA | 820,000+ | Required for all chemo >$500 | 90 days from DOS |
| Humana Gold Plus | 740,000+ | Required; can use CoverMyMeds portal | 12 months from DOS |
| Aetna Medicare Advantage | 310,000+ | Required; clinical criteria follow NCCN guidelines | 180 days from DOS |
| Anthem BCBS MA | 290,000+ | Required for specialty drugs | 90 days from DOS |
| WellCare by Centene | 270,000+ | Required; Gold Carding available after 12 months | 12 months from DOS |
| CarePlus Health Plans | 195,000+ | Required for IMRT/SBRT | 180 days from DOS |
6. Florida Medicaid & MMA Plans for Oncology 2026
Florida's Medicaid Managed Medical Assistance (MMA) program routes most Medicaid oncology patients through managed care plans. Oncology billing under Florida Medicaid requires separate credentialing, prior authorization processes, and formulary compliance for each MMA plan.
| Florida MMA Plan | Oncology Drug PA Process | Chemotherapy Formulary | Key Contact |
|---|---|---|---|
| Molina Healthcare FL | Online portal; 72-hr standard; 24-hr urgent | NCCN-based; step therapy required | Provider line: 1-855-322-4081 |
| Simply Healthcare | Fax or portal; 5-day standard | Open formulary for NCCN Cat 1 | Provider portal: simplyhealthcareplans.com |
| Sunshine Health (Centene) | eviCore clinical criteria | NCCN preferred agents | Provider line: 1-844-477-8633 |
| Florida Community Care | Fax-based; 3-day standard | Restricted; prior auth for all agents | Provider line: 1-877-615-4022 |
| Aetna Better Health FL | Gold Carding after 12-month history | NCCN-aligned preferred list | eviCore for radiation oncology |
| Staywell by WellCare | CoverMyMeds integration | Standard formulary; exceptions available | Provider line: 1-800-278-0820 |
Some Medicaid patients remain in Fee-for-Service (FFS) Medicaid — primarily those with serious and complex medical conditions, certain waiver recipients, and new enrollees during plan selection periods. For FFS Medicaid oncology billing in Florida, claims are processed through the Florida MMIS (Medicaid Management Information System). The enrolled provider portal is the Florida Medicaid Web Portal (mymedicaid-florida.com). FFS Medicaid oncology reimbursement averages 65–75% of Medicare rates for most services.
8. AI-Powered Oncology RCM: The 2026 Competitive Advantage
Artificial intelligence has fundamentally transformed oncology revenue cycle management in 2026. Florida cancer centers adopting AI-powered RCM platforms are reporting 45% reduction in claim denials, 30% faster payment cycles, and $180K–$420K additional annual collections compared to traditional manual billing workflows. Here's how AI is reshaping every stage of the oncology RCM cycle.
- Automated PA submission to 40+ Florida payers
- Real-time PA status tracking with auto-escalation
- Predicts PA approval probability before treatment
- Reduces PA processing time from 3–5 days to <4 hours
- Integrates with eviCore, CoverMyMeds, and payer portals
- Auto-verifies J-code vs. actual drug dispensed
- Cross-references NDC from pharmacy dispensing records
- Calculates correct units based on dose administered vs. vial size
- Flags wastage automatically for JW/JZ modifier assignment
- Updates ASP pricing quarterly from CMS data feeds
- Predicts denial probability before claim submission (96% accuracy)
- Flags ICD-10/J-code mismatches against payer LCDs
- Automated CCI edit checks eliminate bundling errors
- Real-time eligibility verification at point of care
- Payer-specific scrubbing rules for all Florida MCOs
- Prioritizes A/R follow-up by recovery probability × dollar value
- Auto-generates appeal letters with clinical documentation
- Tracks all Florida payer timely filing deadlines
- Flags accounts approaching TFL 45 days in advance
- Averages 31% reduction in oncology A/R over 90 days
📈 AI-Powered RCM Results for Florida Oncology Practices (2026 Data)
🤖 AI Eligibility Verification for Oncology Patients
Oncology patients often have complex insurance situations — Medicare as primary with supplemental Medigap, Medicare Advantage with carve-out pharmacy benefits, or dual Medicare/Medicaid coverage. AI-powered eligibility verification at MDeRCM verifies all active coverages simultaneously, identifies coordination of benefits (COB) order, confirms drug benefit coverage under Part B vs. Part D, and checks real-time deductible/out-of-pocket status before each treatment visit.
9. MDeRCM Oncology RCM Services in Florida — Complete Overview
MDeRCM provides end-to-end AI-powered oncology revenue cycle management for Florida cancer centers, radiation oncology practices, hematology-oncology groups, and independent oncology physicians. Our Florida-specific oncology billing team combines deep CPT/HCPCS expertise with proprietary AI technology to maximize your collections while keeping you fully compliant with FCSO, Florida Medicaid, and all Florida MCO requirements.
Real-time verification of all payer coverages, oncology drug benefit (Part B vs. Part D), prior authorization requirements, and patient financial responsibility — before every treatment visit.
Learn More →AI-driven PA submission and tracking for all Florida oncology payers. Average PA turnaround: 72 hours. Includes peer-to-peer scheduling, appeal management, and gold carding program optimization.
Learn More →Specialized J-code, NDC, and unit billing for all chemotherapy agents. Quarterly ASP updates, automated JW/JZ modifier assignment, and drug wastage documentation built-in.
Learn More →AI-powered denial root-cause analysis, automated appeal generation with clinical documentation, and systematic appeal tracking. Average 68% appeal overturn rate for Florida oncology practices.
Learn More →Intelligent A/R prioritization, follow-up automation, and payer-specific escalation paths. Reduces oncology A/R >90 days by an average of 31% within the first 6 months.
Learn More →FCSO LCD compliance monitoring, RAC audit defense, OIG exclusion screening, and documentation audits. Protect your Florida oncology practice from costly post-payment audits.
Learn More →🎗️ Florida Oncology Specialties We Serve
📍 Florida Oncology Markets We Serve
Sylvester Comprehensive Cancer Center network, South Florida oncology groups, high Medicare Advantage penetration with UnitedHealthcare & Humana dominant plans.
Moffitt Cancer Center network referrals, Tampa General oncology, St. Joseph's Cancer Institute — complex multi-payer billing including Cigna, Aetna, and WellCare.
UCF Health oncology, AdventHealth Cancer Institute, Orlando Health — mixed Medicare, Medicaid, and commercial payer environment.
Mayo Clinic Florida oncology billing, Baptist MD Anderson, UF Health — FCSO Medicare billing expertise critical for North Florida practices.
Lee Health, NCH healthcare system — high Medicare Advantage concentration; retiree-heavy demographics drive complex COB billing.
Boca Raton Regional, Palm Beach Cancer Center, Cleveland Clinic Martin — affluent market with commercial insurance mix plus high Medicare Supplement volume.
10. FAQ: Oncology Billing in Florida 2026
A: Florida oncology practices experience an average claim denial rate of 28–34% — significantly higher than the 14–18% average for primary care. Prior authorization failures and J-code errors are the leading causes. AI-powered oncology RCM reduces this to below 5%.
A: Yes. Each of Florida's 6 MMA plans (Molina, Simply, Sunshine, Florida Community Care, Aetna Better Health, WellCare/Staywell) requires separate credentialing. Oncology practices must also credential for specialty drug benefits, which are sometimes carved out to a separate PBM or specialty pharmacy manager.
A: Medicare Part B covers drugs administered by infusion or injection in a physician office or outpatient clinic setting. Drugs are reimbursed at ASP+6% (Average Sales Price plus 6%). Hospital outpatient departments are reimbursed under OPPS at packaged or separately payable rates. The NDC and J-code must match exactly on every claim submitted to First Coast Service Options (FCSO), Florida's Medicare MAC.
A: Medicare requires claims to be filed within 12 months of the date of service. Florida Medicaid FFS requires 12 months. Medicare Advantage plans vary by plan — UnitedHealthcare MA requires 90 days; Humana MA requires 12 months; Aetna MA requires 180 days. Missing timely filing deadlines is entirely preventable with proper RCM workflows.
A: Yes — and the data from Florida oncology practices using MDeRCM's AI platform is compelling. Our clients average a 45% reduction in claim denials within the first 6 months, a 98.2% clean claim rate, and 30% faster payment cycles. AI excels at J-code verification, real-time eligibility checks, and payer-specific claim scrubbing that manual billing teams simply cannot match at scale.
A: Absolutely. MDeRCM specializes in revenue cycle management for independent oncology physicians and small oncology practices — not just large cancer centers. We offer scalable solutions starting with billing-only services, with the option to add prior authorization management, eligibility verification, and full RCM as your practice grows.
A: In the Buy and Bill model, the oncology practice purchases chemotherapy drugs directly and bills the payer for the drug plus administration. Accurate billing requires the correct J-code, NDC, units dispensed vs. units administered, drug cost documentation, and wastage calculation. AI-powered billing platforms automate all of these elements, reducing Buy and Bill billing errors by over 60%.
🏁 Conclusion: Win the Oncology Billing Battle in Florida with AI RCM
Florida oncology practices in 2026 face a billing environment of unprecedented complexity — rising prior authorization burdens, quarterly drug price updates, Medicare Advantage penetration exceeding 55%, and Florida Medicaid MMA rules that vary by plan. Practices that continue with manual, reactive billing workflows will continue losing $280K–$650K annually to preventable errors and denials.
The solution is AI-powered oncology revenue cycle management — and MDeRCM delivers exactly that. With specialized oncology billing expertise, Florida payer knowledge, and proprietary AI technology, we help Florida cancer centers, radiation oncology practices, and hematology groups recover maximum reimbursement, reduce denial rates by up to 45%, and focus on what matters most: delivering life-saving cancer care.
Ready to transform your oncology revenue cycle? Contact MDeRCM today for a free oncology billing audit and discover exactly how much revenue your Florida practice is leaving behind.